Mami Ojima
Impact in
-
- Renin-Angiotensin System Studies
- Blood Pressure and Hypertension Studies
- Heart Failure Treatment and Management
-
- Hormonal Regulation and Hypertension
Papers in
-
- Hormonal Regulation and Hypertension 6
- Diabetes Treatment and Management 1
-
- Renin-Angiotensin System Studies 5
- Co-authors
- Keiji Kubo (4 shared papers)Yoshiyuki Inada (7 shared papers)Kohei Nishikawa (5 shared papers)Takeo Wada (6 shared papers)Tsukasa Sanada (6 shared papers)Yumiko Shibouta (4 shared papers)Yasuhisa Kohara (3 shared papers)Hiroki Sakamoto (2 shared papers)
- Journals
- European Journal of Pharmacology (3 papers)Hypertension Research (2 papers)Journal of Medicinal Chemistry (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)The Japanese Journal of Pharmacology (1 paper)
- Partner nations
- Japan
In The Last Decade
Mami Ojima
10 papers receiving 451 citations
Peers
Comparison fields: 5 of 66
- Cardiology and Cardiovascular Medicine 259
- Endocrinology, Diabetes and Metabolism 132
- Organic Chemistry 99
- Molecular Biology 146
- Pharmacology 32
Countries citing papers authored by Mami Ojima
This map shows the geographic impact of Mami Ojima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mami Ojima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mami Ojima more than expected).
Fields of papers citing papers by Mami Ojima
This network shows the impact of papers produced by Mami Ojima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mami Ojima. The network helps show where Mami Ojima may publish in the future.
Co-authors
The 23 scholars most cited alongside Mami Ojima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 128 | |
| 2 | 1997 | 127 | |
| 3 | 1993 | 113 | |
| 4 | 2011 | 45 | |
| 5 | 1994 | 28 | |
| 6 | 1996 | 15 | |
| 7 | 1996 | 15 | |
| 8 | 1997 | 12 | |
| 9 | Angiotensin II receptor antagonistic action of candesartan (CV-11974) in the rabbit aorta | 1996 | 2 |
| 10 | 2019 | 1 |
About Mami Ojima
Mami Ojima is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Cellular and Molecular Neuroscience, Molecular Biology and Building and Construction, having authored 10 papers that have together received 486 indexed citations. Recurring topics across this work include Hormonal Regulation and Hypertension (6 papers), Renin-Angiotensin System Studies (5 papers), Receptor Mechanisms and Signaling (4 papers), Neuropeptides and Animal Physiology (2 papers), Synthesis and Reactions of Organic Compounds (1 paper), Recycling and utilization of industrial and municipal waste in materials production (1 paper), Diabetes Treatment and Management (1 paper) and Pharmacology and Obesity Treatment (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (259 citations), Endocrinology, Diabetes and Metabolism (132 citations), Organic Chemistry (99 citations), Molecular Biology (146 citations) and Pharmacology (32 citations). Mami Ojima has collaborated with scholars based in Japan. Frequent co-authors include Keiji Kubo, Yoshiyuki Inada, Kohei Nishikawa, Takeo Wada, Tsukasa Sanada, Yumiko Shibouta, Yasuhisa Kohara, Hiroki Sakamoto, Takanobu Kuroita and Keiji Kusumoto. Their work appears in journals such as European Journal of Pharmacology, Hypertension Research, Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and The Japanese Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.